
Onco-microTESE proved effective for fertility preservation in sub-fertile testicular cancer patients with azoospermia or severe oligoasthenoteratozoospermia (OAT). Among 31 azoospermic patients, initial onco-microTESE achieved a 61% sperm retrieval success rate, with contralateral procedures raising the overall success to 71%. Additionally, six of seven patients with severe OAT had sperm successfully harvested to enhance fertility preservation. Conducted within a median of 7 days from presentation, the procedure enabled timely oncological treatment while preserving reproductive potential. These findings underscore the importance of assessing fertility status at diagnosis to optimize fertility outcomes in testicular cancer patients.
Like
Save
Share